Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-8 days
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Serum separator tube.
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube (Min: 0.15 mL)
Storage/Transport Temperature
Refrigerated
Unacceptable Conditions
Bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid specimens.
Remarks
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 6 months
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Effective February 17, 2015
Test Number
Components
Reference Interval
Candida Antibody IgA
0.88 EV or less
Negative - No significant level of detectable Candidaalbicans antibody.
0.89-0.99 EV
Equivocal - Questionable presence of antibodies. Repeat testing in 10-14 days may be helpful.
1.00 EV or greater
Positive - Antibody to Candidaalbicans detected, which may indicate a current or past infection.
Candida Antibody IgM
0.88 EV or less
Negative - No significant level of detectable Candidaalbicans antibody.
0.89-0.99 EV
Equivocal - Questionable presence of antibodies. Repeat testing in 10-14 days may be helpful.
1.00 EV or greater
Positive - Antibody to Candidaalbicans detected, which may indicate a current or past infection.
Candida Antibody IgA
0.88 EV or less
Negative - No significant level of detectable Candidaalbicans antibody.
0.89-0.99 EV
Equivocal - Questionable presence of antibodies. Repeat testing in 10-14 days may be helpful.
1.00 EV or greater
Positive - Antibody to Candidaalbicans detected, which may indicate a current or past infection.
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
The best evidence for current infection is a significant change on two appropriately timed specimens where both tests are done in the same laboratory at the same time. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
C albicans antibodies
Candida antibodies
Candida IgG, IgM, IgA Ab Panel
Candida albicans Antibodies IgA, IgG, and IgM by ELISA
Chat
Feedback
